Beauty Farm Medical and Health Industry Inc. (HKG:2373)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
18.20
-0.31 (-1.67%)
Sep 2, 2026, 4:08 PM HKT

HKG:2373 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
384.04317.56228.46215.66103.11193.48
Depreciation & Amortization
441.7398.4377.24327.72293.81272.89
Other Amortization
6.346.345.344.023.432.3
Loss (Gain) From Sale of Assets
13.9613.967.081.010.912.64
Asset Writedown & Restructuring Costs
-----0.03
Loss (Gain) From Sale of Investments
-17.48-17.48-20.68-23.85-20.7-23.41
Loss (Gain) on Equity Investments
---0.05--
Stock-Based Compensation
16.7616.76-0.3810.914.186.29
Provision & Write-off of Bad Debts
1.041.043.91-0.05-0.031.31
Other Operating Activities
110.2678.8853.4455.1933.7740.63
Change in Accounts Receivable
22.6722.6762.84-24.68-35.3-9.32
Change in Inventory
52.2152.2156.3-47.95-46.36-31.73
Change in Accounts Payable
48.248.2-9.7445.76-26.3359.23
Change in Unearned Revenue
61.0861.0850.8361.9161.54165.86
Change in Other Net Operating Assets
-0.54-0.54-18-0.17-0.03-10.25
Operating Cash Flow
1,140999.09796.63625.51382669.93
Operating Cash Flow Growth
15.85%25.42%27.36%63.75%-42.98%-1.56%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-67.08-67.08-114.18-159.24-140.79-133.17
Sale of Property, Plant & Equipment
0.030.032.690.60.22-
Cash Acquisitions
-249.86-249.86-245.34-7.5-4.2-11.3
Divestitures
110.08--2.133.66
Investment in Securities
-99.46-99.46-4.13-551.11200.52-244.54
Other Investing Activities
-374.2618.9420.046.06--
Investing Cash Flow
-789.63-396.42-340.85-711.1953.63-385.35

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-614.04157.5---
Long-Term Debt Repaid
--304.42-273.43-232.08-231.43-183.87
Net Debt Issued (Repaid)
309.62309.62-115.93-232.08-231.43-183.87
Issuance of Common Stock
---506.553.9818.33
Repurchase of Common Stock
-24.89-24.89--12.01--
Common Dividends Paid
-122.27-122.27-112.49-87-204.26-81.16
Other Financing Activities
-261.54-110.685.06-41.72-1.1-24.36
Financing Cash Flow
-99.0851.79-223.36133.74-432.82-271.07

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.75-0.75-0.5312.094.030.23
Net Cash Flow
250.8653.71231.8860.166.8413.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,073932.01682.44466.27241.21536.76
Free Cash Flow Growth
16.35%36.57%46.36%93.31%-55.06%-12.44%
Free Cash Flow Margin
31.35%31.06%26.53%21.74%14.75%30.14%
Free Cash Flow Per Share
4.494.022.972.031.212.69
Levered Free Cash Flow
1,543767.661,067435.97196.28503.06
Unlevered Free Cash Flow
1,569787.761,084451.48211.73518.2

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
7.127.122.88--0.02
Cash Income Tax Paid
57.6257.6242.4628.1927.0945.93
Change in Working Capital
183.62183.62142.2334.87-46.48173.78